Recruiting studies: Pre Bronchiolitis Obliterans Syndrome

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study to Evaluate Axatilimab Versus Best Available Therapy in Pediatric Participants With Chronic Graft-Versus-Host Di
Phase 2 · 41 location(s) · Incyte Corporation · NCT07124078 A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
Phase 2 · 26 location(s) · Deciphera Pharmaceuticals, LLC · NCT06619561 Study to Evaluate ARINA-1 in the Prevention of Bronchiolitis Obliterans Progression in Participants With Bilateral Lung
Phase 3 · 20 location(s) · Renovion, Inc. · NCT05654922 Gecacitinib for cGVHD: Safety and Efficacy in Patients After ≥2 Lines of Prior Therapy
Phase 1/Phase 2 · 1 location(s) · Yujun DONG · NCT07012304 Belumosudil for the Pre-emptive Treatment of Patients With Chronic Graft Versus Host Disease
Phase 2 · 5 location(s) · Fred Hutchinson Cancer Center · NCT05996627

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.